The 27 most recent market catalysts affecting $TMO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 10, 2026
Corporate Catalyst
Bullish
Impact 55
Thermo Fisher Scientific Announces Multiple Installations of Optis™ FIB-SEM for Semiconductor Manufacturing
Thermo Fisher Scientific announced the successful installation of multiple Optis FIB-SEM systems, which are critical for advanced semiconductor manufacturing. This development is s…
Nov 6, 2026
Corporate Catalyst
Bullish
Impact 65
Thermo Fisher Scientific Authorizes $5 Billion Share Repurchase Program
Thermo Fisher Scientific announced a new $5 billion share repurchase authorization, replacing an existing program with $1 billion remaining. This action indicates the company's str…
Nov 2, 2026
Corporate Catalyst
Neutral
Impact 55
Thermo Fisher Scientific Announces 800 Million Swiss Franc Bond Issuance
Thermo Fisher Scientific announced the issuance of CHF 800 million in bonds, divided into four tranches with maturities ranging from 3 to 12 years and coupon rates between 1.1450% …
Oct 30, 2026
Corporate Catalyst
Neutral
Impact 55
Thermo Fisher Scientific Executive Vice President Michael D. Shafer to Retire
Thermo Fisher Scientific disclosed that Executive Vice President Michael D. Shafer will retire on December 31, 2026. This is a standard executive transition, but the extended timel…
Oct 28, 2026
Corporate Catalyst
Bearish
Impact 55
Evercore ISI Adjusts Thermo Fisher Scientific Price Target
Evercore ISI, an analyst firm, has reduced its price target for Thermo Fisher Scientific (TMO) from $720 to $615. This action signals a less favorable valuation assessment by the f…
Oct 24, 2026
Corporate Catalyst
Bullish
Impact 55
Citi Maintains Buy Rating and Raises Price Target for Thermo Fisher Scientific
Citi analyst Patrick B. Donnelly reaffirmed a 'Buy' rating for Thermo Fisher Scientific (TMO) and raised the price target from $685 to $800. This indicates a strengthened positive …
Oct 22, 2026
Corporate Catalyst
Neutral
Impact 65
Analysts Adjust Price Targets for Thermo Fisher Scientific
On October 22, 2026, multiple prominent financial firms, including TD Cowen, Stifel, Goldman Sachs, and Barclays, raised their price targets for Thermo Fisher Scientific. This coll…
Oct 21, 2026
Corporate Catalyst
Neutral
Impact 75
Thermo Fisher Exec Says Co Expects Adj. EPS To Be In The Range Of $25.13 - $25.43
Thermo Fisher Scientific (TMO) has provided updated adjusted EPS guidance, setting an expected range of $25.13 to $25.43. This information, likely shared during an investor event o…
Oct 21, 2026
Corporate Catalyst
Neutral
Impact 55
Thermo Fisher Exec Says Co. Expects Full Year Revenue To Be In The Range Of $47.7B - $48.2B
The 8-K filing points to an executive statement from Thermo Fisher Scientific, reiterating their full-year revenue guidance of $47.7 billion to $48.2 billion. This is not a new ann…
Oct 20, 2026
Corporate Catalyst
Bullish
Impact 65
Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings
This filing primarily focuses on Thermo Fisher Scientific's (TMO) upcoming Q3 earnings report and the positive sentiment from several top Wall Street analysts. Analysts are forecas…
Oct 14, 2026
Corporate Catalyst
Neutral
Impact 65
CNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer
The 'Final Trades' segment on CNBC's Halftime Report often features specific stock recommendations from panelists, which can generate short-term trading activity and increased inve…
Oct 13, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $760
TD Cowen analyst Dan Brennan has maintained a 'Buy' rating on Thermo Fisher Scientific (TMO) and raised the price target from $675 to $760. This action signals increased confidence…
Oct 7, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750
Barclays analyst Luke Sergott has maintained an 'Overweight' rating on Thermo Fisher Scientific (TMO) and raised the price target from $650 to $750. This action signals a strong co…
Sep 28, 2026
Corporate Catalyst
Bullish
Impact 55
Thermo Fisher Scientific To Add Evosep Eno To Mass Spectrometry Portfolio In Reseller Agreement Combining Global Commercial Reach With Evosep's Separation Technology
This reseller agreement is a positive development for Thermo Fisher Scientific, enhancing its mass spectrometry portfolio and leveraging its extensive global commercial network. Fo…
Sep 24, 2026
Corporate Catalyst
Bullish
Impact 92
Thermo Fisher Stock Hits Record High: What's Happening?
Thermo Fisher Scientific (TMO) shares hit an all-time high of $681.55, extending gains from a strong Q2 earnings report where adjusted earnings and sales beat estimates. The compan…
Sep 22, 2026
Market Technicals
Bearish
Impact 65
Top 3 Health Care Stocks That May Keep You Up At Night This Month
The filing identifies Thermo Fisher Scientific (TMO), Moderna (MRNA), and Agilent Technologies (A) as having RSI values above 70, indicating they are technically overbought. This m…
Sep 15, 2026
Corporate Catalyst
Bullish
Impact 75
Thermo Fisher Scientific after a company executive said at an industry conference that orders are outpacing revenue, which in its view bodes well for future growth.
The executive's comment signals robust demand for Thermo Fisher's offerings, which is a strong leading indicator for future revenue. This positive outlook could boost TMO's stock p…
Sep 15, 2026
Corporate Catalyst
Bullish
Impact 65
Thermo Fisher Scientific Exec Says At Morgan Stanley Conference Orders Are Outpacing Revenue, Boding Well For Future Growth
A Thermo Fisher Scientific executive disclosed at a Morgan Stanley conference that the company is experiencing orders outpacing revenue. This is a significant positive indicator as…
Sep 3, 2026
Corporate Catalyst
Neutral
Impact 65
CLSA Initiates Coverage On Thermo Fisher Scientific with Outperform Rating, Announces Price Target of $748
CLSA's initiation of coverage on Thermo Fisher Scientific with an Outperform rating and a $748 price target is a positive development for the company. Analyst initiations, especial…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 65
Thermo Fisher Says India Is One Of Its Fastest-Growing Markets
Thermo Fisher Scientific (TMO) is projecting 15-20% customer base growth in India over the next five years, fueled by the country's burgeoning biopharmaceutical, clean energy, and …
Jul 27, 2026
Corporate Catalyst
Neutral
Impact 55
Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600
Piper Sandler analyst David Westenberg maintained a 'Neutral' rating on Thermo Fisher Scientific but raised the price target from $510 to $600. This action suggests that while the …
Jul 24, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650
Barclays analyst Luke Sergott maintained an 'Overweight' rating on Thermo Fisher Scientific and raised the price target from $625 to $650. This action signals continued confidence …
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 92
Thermo Fisher Points to Improving End-Market Activity
Thermo Fisher Scientific's Q2 earnings and revenue significantly surpassed analyst estimates, indicating robust performance. The company's upward revision of its full-year guidance…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Danaher shares are trading higher amid sympathy with Thermo Fisher after that company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates.
This headline indicates a significant positive catalyst for Danaher, driven by a 'sympathy' trade with Thermo Fisher. Thermo Fisher's strong Q2 results and raised FY26 EPS guidance…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Thermo Fisher Scientific Exec Says Raising 2026 Revenue Forecast To Between $47.4B - $48.1B; Raising 2026 Adj EPS View To $24.93 - $25.33
Thermo Fisher Scientific (TMO) has raised its 2026 revenue forecast to between $47.4B - $48.1B and its adjusted EPS view to $24.93 - $25.33. This upward revision signals management…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Thermo Fisher Scientific shares are trading higher after the company reported better-than-expected Q2 financial results.
This headline represents a significant corporate catalyst for Thermo Fisher Scientific, directly impacting its stock price positively due to strong financial performance. The bette…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 85
Thermo Fisher Scientific Q2 Adj. EPS $6.03 Beats $5.71 Estimate, Sales $11.994B Beat $11.701B Estimate
Thermo Fisher Scientific's Q2 earnings and sales significantly surpassed analyst estimates, demonstrating strong financial health and operational execution. This positive performan…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.